Molecular biology and genetic diversity of Rift Valley fever virus

被引:100
作者
Ikegami, Tetsuro [1 ,2 ,3 ]
机构
[1] Univ Texas Med Branch, Dept Pathol, MMNP3-206D,301 Univ Blvd, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA
关键词
Rift Valley fever virus; Bunyavirus; Phlebovirus; Genetic diversity; Phylogenetics; MEDIATED ISOTHERMAL AMPLIFICATION; POLYMERASE CHAIN-REACTION; RNA GENOME SEGMENTS; NSS PROTEIN; RAPID DETECTION; NONCODING REGIONS; SANDFLY FEVER; WILD-TYPE; IN-VIVO; TRANSCRIPTION;
D O I
10.1016/j.antiviral.2012.06.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rift Valley fever virus (RVFV), a member of the family Bunyaviridae, genus Phlebovirus, is the causative agent of Rift Valley fever (RVF), a mosquito-borne disease of ruminant animals and humans. The generation of a large sequence database has facilitated studies of the evolution and spread of the virus. Bayesian analyses indicate that currently circulating strains of RVFV are descended from an ancestral species that emerged from a natural reservoir in Africa when large-scale cattle and sheep farming were introduced during the 19th century. Viruses descended from multiple lineages persist in that region, through infection of reservoir animals and vertical transmission in mosquitoes, emerging in years of heavy rainfall to cause epizootics and epidemics. On a number of occasions, viruses from these lineages have been transported outside the enzootic region through the movement of infected animals or mosquitoes, triggering outbreaks in countries such as Egypt, Saudi Arabia, Mauritania and Madagascar, where RVF had not previously been seen. Such viruses could potentially become established in their new environments through infection of wild and domestic ruminants and other animals and vertical transmission in local mosquito species. Despite their extensive geographic dispersion, all strains of RVFV remain closely related at the nucleotide and amino acid level. The high degree of conservation of genes encoding the virion surface glycoproteins suggests that a single vaccine should protect against all currently circulating RVFV strains. Similarly, preservation of the sequence of the RNA-dependent RNA polymerase across viral lineages implies that antiviral drugs targeting the enzyme should be effective against all strains. Researchers should be encouraged to collect additional RVFV isolates and perform whole-genome sequencing and phylogenetic analysis, so as to enhance our understanding of the continuing evolution of this important virus. This review forms part of a series of invited papers in Antiviral Research on the genetic diversity of emerging viruses. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:293 / 310
页数:18
相关论文
共 50 条
  • [41] Diagnostic Approaches for Rift Valley Fever
    Wilson, W. C.
    Weingartl, H. M.
    Drolet, B. S.
    Dave, K.
    Harpster, M. H.
    Johnson, P. A.
    Faburay, B.
    Ruder, M. G.
    Richt, J. A.
    McVey, D. S.
    VACCINES AND DIAGNOSTICS FOR TRANSBOUNDARY ANIMAL DISEASES, 2013, 135 : 73 - 78
  • [42] Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe
    Mansfield, Karen L.
    Banyard, Ashley C.
    McElhinney, Lorraine
    Johnson, Nicholas
    Horton, Daniel L.
    Hernandez-Triana, Luis M.
    Fooks, Anthony R.
    VACCINE, 2015, 33 (42) : 5520 - 5531
  • [43] Creation of a Recombinant Rift Valley Fever Virus with a Two-Segmented Genome
    Brennan, Benjamin
    Welch, Stephen R.
    McLees, Angela
    Elliott, Richard M.
    JOURNAL OF VIROLOGY, 2011, 85 (19) : 10310 - 10318
  • [44] Protein Phosphatase-1 regulates Rift Valley fever virus replication
    Baer, Alan
    Shafagati, Nazly
    Benedict, Ashwini
    Ammosova, Tatiana
    Ivanov, Andrey
    Hakami, Ramin M.
    Terasaki, Kaori
    Makino, Shinji
    Nekhai, Sergei
    Kehn-Hall, Kylene
    ANTIVIRAL RESEARCH, 2016, 127 : 79 - 89
  • [45] Experimental Infection of Domestic Pigs (Sus scrofa) with Rift Valley Fever Virus
    Lubisi, Baratang Alison
    Mutowembwa, Paidamwoyo Barry
    Ndouvhada, Phumudzo Nomicia
    Odendaal, Lieza
    Bastos, Armanda D. S.
    Penrith, Mary-Louise
    VIRUSES-BASEL, 2023, 15 (02):
  • [46] Recombinase polymerase amplification assay for rapid detection of Rift Valley fever virus
    Euler, Milena
    Wang, Yongjie
    Nentwich, Oliver
    Piepenburg, Olaf
    Hufert, Frank T.
    Weidmann, Manfred
    JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (04) : 308 - 312
  • [47] Phylogeography of Rift Valley Fever Virus in Africa and the Arabian Peninsula
    Samy, Abdallah M.
    Peterson, A. Townsend
    Hall, Matthew
    PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (01):
  • [48] Enhanced detection of Rift Valley fever virus using molecular assays on whole blood samples
    Grolla, Allen
    Mehedi, Masfique
    Lindsay, Robbin
    Bosio, Catharine
    Duse, Adriano
    Feldmann, Heinz
    JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (04) : 313 - 317
  • [49] Rift Valley Fever Virus Infection in Golden Syrian Hamsters
    Scharton, Dionna
    Van Wettere, Amaud J.
    Bailey, Kevin W.
    Vest, Zachary
    Westover, Jonna B.
    Siddharthan, Venkatraman
    Gowen, Brian B.
    PLOS ONE, 2015, 10 (01):
  • [50] Reverse genetics technology for Rift Valley fever virus: Current and future applications for the development of therapeutics and vaccines
    Bouloy, Michele
    Flick, Ramon
    ANTIVIRAL RESEARCH, 2009, 84 (02) : 101 - 118